Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2012, Article ID 274363, 8 pages
http://dx.doi.org/10.1155/2012/274363
Research Article

Amelioration of Glucose Control Mobilizes Circulating Pericyte Progenitor Cells in Type 2 Diabetic Patients with Microangiopathy

1Department of Clinical and Experimental Medicine, University of Padova, 35128 Padova, Italy
2Venetian Institute of Molecular Medicine, 35129 Padova, Italy
3European Institute of Oncology, 20141 Milan, Italy

Received 5 December 2011; Accepted 20 December 2011

Academic Editor: Paolo Madeddu

Copyright © 2012 Gian Paolo Fadini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Brownlee, “The pathobiology of diabetic complications: a unifying mechanism,” Diabetes, vol. 54, no. 6, pp. 1615–1625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. G. P. Fadini, S. Sartore, C. Agostini, and A. Avogaro, “Significance of endothelial progenitor cells in subjects with diabetes,” Diabetes Care, vol. 30, no. 5, pp. 1305–1313, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. G. P. Fadini, “Is bone marrow another target of diabetic complications?” European Journal of Clinical Investigation, vol. 41, no. 4, pp. 457–463, 2011. View at Publisher · View at Google Scholar
  4. T. Asahara, H. Masuda, T. Takahashi et al., “Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization,” Circulation Research, vol. 85, no. 3, pp. 221–228, 1999. View at Google Scholar · View at Scopus
  5. M. Albiero, L. Menegazzo, and G. P. Fadini, “Circulating smooth muscle progenitors and atherosclerosis,” Trends in Cardiovascular Medicine, vol. 20, no. 4, pp. 133–140, 2010. View at Publisher · View at Google Scholar
  6. G. P. Fadini, M. Albiero, L. Menegazzo et al., “Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes,” Circulation Research, vol. 108, no. 9, pp. 1112–1121, 2011. View at Publisher · View at Google Scholar
  7. W. Wojakowski, M. Tendera, M. Kucia et al., “Cardiomyocyte differentiation of bone marrow-derived Oct-4 +CXCR4+SSEA-1+ very small embryonic-like stem cells,” International Journal of Oncology, vol. 37, no. 2, pp. 237–247, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. A. D. Blann, A. Woywodt, F. Bertolini et al., “Circulating endothelial cells. Biomarker of vascular disease,” Thrombosis and Haemostasis, vol. 93, no. 2, pp. 228–235, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. G. P. Fadini, L. Pucci, R. Vanacore et al., “Glucose tolerance is negatively associated with circulating progenitor cell levels,” Diabetologia, vol. 50, no. 10, pp. 2156–2163, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. S. Yoon, S. Uchida, O. Masuo et al., “Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor,” Circulation, vol. 111, no. 16, pp. 2073–2085, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Q. Nguyen, H. Chon, F. A. Van Nieuwenhoven, B. Braam, M. C. Verhaar, and R. Goldschmeding, “Myofibroblast progenitor cells are increased in number in patients with type 1 diabetes and express less bone morphogenetic protein 6: a novel clue to adverse tissue remodelling?” Diabetologia, vol. 49, no. 5, pp. 1039–1048, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. J. A. McClung, N. Naseer, M. Saleem et al., “Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA1c,” Diabetologia, vol. 48, no. 2, pp. 345–350, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Mancuso, I. Martin-Padura, A. Calleri et al., “Circulating perivascular progenitors: a target of PDGFR inhibition,” International Journal of Cancer, vol. 129, no. 6, pp. 1344–1350, 2011. View at Publisher · View at Google Scholar
  14. A. Armulik, A. Abramsson, and C. Betsholtz, “Endothelial/pericyte interactions,” Circulation Research, vol. 97, no. 6, pp. 512–523, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Hellström, M. Kalén, P. Lindahl, A. Abramsson, and C. Betsholtz, “Role of PDGF-B and PDGFR-β in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse,” Development, vol. 126, no. 14, pp. 3047–3055, 1999. View at Google Scholar · View at Scopus
  16. P. Lindahl, B. R. Johansson, P. Levéen, and C. Betsholtz, “Pericyte loss and microaneurysm formation in PDGF-B-deficient mice,” Science, vol. 277, no. 5323, pp. 242–245, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. G. P. Fadini, S. V. de Kreutzenberg, V. Mariano et al., “Optimized glycaemic control achieved with add-on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargine,” Diabetes, Obesity and Metabolism, vol. 13, no. 8, pp. 718–725, 2011. View at Publisher · View at Google Scholar
  18. Early Treatment Diabetic Retinopathy Study Research Group, “Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11,” Ophthalmology, vol. 98, pp. 807–822, 1991. View at Google Scholar
  19. A. S. Levey, L. A. Stevens, C. H. Schmid et al., “A new equation to estimate glomerular filtration rate,” Annals of Internal Medicine, vol. 150, no. 9, pp. 604–612, 2009. View at Google Scholar · View at Scopus
  20. W. Wojakowski, M. Z. Ratajczak, and M. Tendera, “Mobilization of very small embryonic-like stem cells in acute coronary syndromes and stroke,” Herz, vol. 35, no. 7, pp. 467–473, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Shimizu, Y. Sano, H. Haruki, and T. Kanda, “Advanced glycation end-products induce basement membrane hypertrophy in endoneurial microvessels and disrupt the blood-nerve barrier by stimulating the release of TGF-β and vascular endothelial growth factor (VEGF) by pericytes,” Diabetologia, vol. 54, no. 6, pp. 1517–1526, 2011. View at Publisher · View at Google Scholar
  22. J. I. Kreisberg and S. H. Ayo, “The glomerular mesangium in diabetes mellitus,” Kidney International, vol. 43, no. 1, pp. 109–113, 1993. View at Google Scholar · View at Scopus
  23. D. Shepro and N. M. L. Morel, “Pericyte physiology,” FASEB Journal, vol. 7, no. 11, pp. 1031–1038, 1993. View at Google Scholar · View at Scopus
  24. M. Mizutani, T. S. Kern, and M. Lorenzi, “Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy,” Journal of Clinical Investigation, vol. 97, no. 12, pp. 2883–2890, 1996. View at Google Scholar · View at Scopus
  25. G. P. Fadini, S. Sartore, M. Schiavon et al., “Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats,” Diabetologia, vol. 49, no. 12, pp. 3075–3084, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Aicher, M. Rentsch, K. I. Sasaki et al., “Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia,” Circulation Research, vol. 100, no. 4, pp. 581–589, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Katare, F. Riu, K. Mitchell et al., “Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132,” Circulation Research, vol. 109, no. 8, pp. 894–906, 2011. View at Publisher · View at Google Scholar
  28. P. Campagnolo, D. Cesselli, A. Al Haj Zen et al., “Human adult vena saphena contains perivascular progenitor cells endowed with clonogenic and proangiogenic potential,” Circulation, vol. 121, no. 15, pp. 1735–1745, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Grunewald, I. Avraham, Y. Dor et al., “VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells,” Cell, vol. 124, no. 1, pp. 175–189, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Treins, S. Giorgetti-Peraldi, J. Murdaca, G. L. Semenza, and E. Van Obberghen, “Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway,” Journal of Biological Chemistry, vol. 277, no. 31, pp. 27975–27981, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Jacob, J. D. Molkentin, A. Smolenski, S. M. Lohmann, and N. Begum, “Insulin inhibits PDGF-directed VSMC migration via NO/cGMP increase of MKP-1 and its inactivation of MAPKs,” American Journal of Physiology, vol. 283, no. 3, pp. C704–C713, 2002. View at Google Scholar · View at Scopus
  32. A. Aljada, J. Friedman, H. Ghanim et al., “Glucose ingestion induces an increase in intranuclear nuclear factor κB, a fall in cellular inhibitor κB, and an increase in tumor necrosis factor α messenger RNA by mononuclear cells in healthy human subjects,” Metabolism: Clinical and Experimental, vol. 55, no. 9, pp. 1177–1185, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Van Ballegooie, J. M. M. Hooymans, and Z. Timmerman, “Rapid deterioration of diabetic retinopathy during treatment with continuous subcutaneous insulin infusion,” Diabetes Care, vol. 7, no. 3, pp. 236–242, 1984. View at Google Scholar · View at Scopus
  34. C. H. Gibbons and R. Freeman, “Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy,” Annals of Neurology, vol. 67, no. 4, pp. 534–541, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Dar, H. Domev, O. Ben-Yosef et al., “Multipotent vasculogenic pericytes from human pluripotent stem cells promote recovery of murine ischemic limb,” Circulation, vol. 2012, no. 125, pp. 1–87, 99. View at Google Scholar
  36. A. Schober, M. Hristov, S. Kofler et al., “CD34+CD140b+ cells and circulating CXCL12 correlate with the angiographically assessed severity of cardiac allograft vasculopathy,” European Heart Journal, vol. 32, no. 4, pp. 476–484, 2011. View at Publisher · View at Google Scholar